FATE THERAPEUTICS INC (FATE)
Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting
Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting
Global Payments Announces Exclusive Agreement with CKE Restaurants
TRON INC. REPORTS FIRST QUARTER 2026 RESULTS
ARRAY Technologies to Participate in Upcoming Investor Conferences
SoundThinking Honors Law Enforcement During National Police Week 2026
Celanese Announces Price Increases Across the Acetyl Chain
Cruise Ship Virus Outbreaks Highlight Massive Emerging Demand for TOMI Environmental Solutions’ SteraMist Technology
Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle
Pagaya Announces New Affiliate Partnership with Experian® to Expand Access to Personal Loans
Standard Motor Products, Inc. Announces Executive Leadership Changes